BR9807694A - of an active principle - Google Patents

of an active principle

Info

Publication number
BR9807694A
BR9807694A BR9807694A BR9807694A BR9807694A BR 9807694 A BR9807694 A BR 9807694A BR 9807694 A BR9807694 A BR 9807694A BR 9807694 A BR9807694 A BR 9807694A BR 9807694 A BR9807694 A BR 9807694A
Authority
BR
Brazil
Prior art keywords
weight
active principle
anionic
somatic
polysorbate
Prior art date
Application number
BR9807694A
Other languages
Portuguese (pt)
Inventor
Jean-Claude Gautier
Xavier Boulenc
Regine Bellamy
Bernard Abramovici
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of BR9807694A publication Critical patent/BR9807694A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

DE UM PRINCìPIO ATIVO". A invenção refere-se a uma composição farmacêutica para a administração oral de compostos heterocíclicos sob forma de amónio quaternário, que contém: princípio ativo 0,1 a 15% em peso, solvente hidrófilo: 0 a 60% em peso, tensoativo aniónico: 0 a 5% em peso, polissorbato 80:soativo aniónico esteja presente. OF AN ACTIVE PRINCIPLE ". The invention relates to a pharmaceutical composition for the oral administration of heterocyclic compounds in the form of quaternary ammonium, which contains: active ingredient 0.1 to 15% by weight, hydrophilic solvent: 0 to 60% in weight, anionic surfactant: 0 to 5% by weight, polysorbate 80: anionic somatic is present.

BR9807694A 1997-02-17 1998-02-17 of an active principle BR9807694A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9701825A FR2759584B1 (en) 1997-02-17 1997-02-17 PHARMACEUTICAL COMPOSITION FOR THE ORAL ADMINISTRATION OF HETEROCYCLIC COMPOUNDS IN QUATERNARY AMMONIUM FORM
PCT/FR1998/000298 WO1998035662A1 (en) 1997-02-17 1998-02-17 Pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammonium

Publications (1)

Publication Number Publication Date
BR9807694A true BR9807694A (en) 2000-03-21

Family

ID=9503804

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9807694A BR9807694A (en) 1997-02-17 1998-02-17 of an active principle

Country Status (11)

Country Link
EP (1) EP0969825A1 (en)
JP (1) JP2001511795A (en)
AR (1) AR011805A1 (en)
AU (1) AU6404998A (en)
BR (1) BR9807694A (en)
CA (1) CA2281560A1 (en)
FR (1) FR2759584B1 (en)
HR (1) HRP980075A2 (en)
NO (1) NO993928L (en)
WO (1) WO1998035662A1 (en)
ZA (1) ZA981289B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102188424B (en) * 2011-03-23 2013-03-27 浙江理工大学 Anti-leukemia effects of SR140333

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676054B1 (en) * 1991-05-03 1993-09-03 Sanofi Elf NOVEL N-ALKYLENEPIPERIDINO COMPOUNDS AND THEIR ENANTIOMERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2676055B1 (en) * 1991-05-03 1993-09-03 Sanofi Elf AMINO POLYCYCLIC COMPOUNDS AND THEIR ENANTIOMERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2688219B1 (en) * 1992-03-03 1994-07-08 Sanofi Elf AMATONIUM QUATERNARY SALTS OF AMINO AROMATIC COMPOUNDS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2696178B1 (en) * 1992-09-30 1994-12-30 Sanofi Elf Quaternary basic amides, process for their preparation and pharmaceutical compositions containing them.
FR2717804B1 (en) * 1994-03-25 1996-06-21 Sanofi Sa Salts of substituted nitrogen heteroaromatic compounds, process for their preparation and pharmaceutical compositions containing them.
EP0777666B1 (en) * 1994-08-25 1999-03-03 Merrell Pharmaceuticals Inc. Substituted piperidines useful for the treatment of allergic diseases
FR2725986B1 (en) * 1994-10-21 1996-11-29 Adir NOVEL PIPERIDINE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2725900B1 (en) * 1994-10-21 1997-07-18 Sanofi Sa USE OF NK1 RECEPTOR ANTAGONISTS FOR THE PREPARATION OF DRUGS WITH CARDIOREGULATORY ACTION
FR2729951B1 (en) * 1995-01-30 1997-04-18 Sanofi Sa NOVEL HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2729954B1 (en) * 1995-01-30 1997-08-01 Sanofi Sa SUBSTITUTED HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
EP0969825A1 (en) 2000-01-12
ZA981289B (en) 1998-08-26
HRP980075A2 (en) 1998-10-31
NO993928D0 (en) 1999-08-16
FR2759584B1 (en) 1999-06-11
AU6404998A (en) 1998-09-08
WO1998035662A1 (en) 1998-08-20
CA2281560A1 (en) 1998-08-20
AR011805A1 (en) 2000-09-13
JP2001511795A (en) 2001-08-14
FR2759584A1 (en) 1998-08-21
NO993928L (en) 1999-08-16

Similar Documents

Publication Publication Date Title
BRPI0015567B8 (en) compound, pharmaceutical composition, dosage unit form, use of the pharmaceutical composition and method for preparing a pharmaceutical composition
ES2192234T3 (en) PARENTERAL PHARMACEUTICAL COMPOSITIONS CONTAINING SALTS OF 2-ARILPROPIONIC ACIDS.
YU13695A (en) Application of 2-phenyl-3-aroylbenzothiophene and pharmaceutical formulations thereof
BR9912694A (en) Compound to prepare pulmonary administration medication
BRPI0518266A2 (en) modified-release oral medicinal product of at least one active ingredient in multi-capsule form
ATE270544T1 (en) SEMI-SOLID MEDICINAL PREPARATION CONTAINING ISOTRETINOIN
NO2011026I2 (en) Eribulin or a pharmaceutically acceptable salt thereof
BR0108893A (en) Pharmaceutical composition, compound and compound preparation process
NO20000466D0 (en) Pharmaceutical preparation for acidic, lipophilic compounds in the form of a self-emulsifying formulation
IS4224A (en) A pharmaceutical formulation in the form of a droplet containing a short-acting calcium antidote of the dihydropyridine antidepressant
AR033688A1 (en) RECONSTITUABLE PARENTERAL COMPOSITION
BR0207872A (en) Active agent release compound, composition, unit dosage form and method of administration
BR9201854A (en) COMPOSITE DERIVED FROM PRIDAZINES, PROCESS FOR ITS PREPARATION, AND PHARMACEUTICAL COMPOSITION
BR0212069A (en) Oral antidiabetic agents
DK1140031T3 (en) Pharmaceutical composition for controlled release with tilidine mesylate as active substance
NO942952D0 (en) 11-benzaldoxyn-17 aters, a process for their preparation and a medicament containing such
RS50046B (en) PHARMACEUTICAL COMPOSITIONS OF TIZOXANIDE AND NITAZOXANIDE
TR200000153T2 (en) 6-azauracil derivatives that inhibit il-5.
BRPI0409088A (en) pharmaceutical compositions for intranasal administration of [2- (8,9-dioxo-2,6-diazabicyclo [5.2.0] non-1 (7) -en-2-yl) alkyl] -phosphonic acid and derivatives and methods of use of the same
BR9807406A (en) Pharmaceutical formulation, and process for preparing them
BR9807694A (en) of an active principle
BR9807506A (en) Amide derivatives and medicinal compositions thereof
KR900012925A (en) Indole derivatives
ES2065192T3 (en) NEW NICOTINATES OF DIACIL-GLYCEROL, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ES2179667T3 (en) NEW INJECTABLE FORMULATIONS CONTAINING RAMOPLANIN.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]